SOURCE: IDenta Corp.

October 15, 2007 09:15 ET

International Drug & Explosives Detection Firm IDenta Completes the Development and Product Packaging of the New Detector for Date Rape Drug -- GHB

JERUSALEM, ISRAEL--(Marketwire - October 15, 2007) - IDenta Corp. (PINKSHEETS: IDTA) today announced it has completed the development and product packaging of the new IDenta GHB Drug Detector.

In a previous press release at August 30, 2007 the company has announced that the testing (chemical tests) of its latest drug detector designed to positively detect the presence of GHB, Gamma hydroxybutyrate, also known as 'The Date Rape Drug' has been completed.

Since then the company has been involved in developing the kit as a user-friendly device.

Today the company is happy to announce that the new device for testing and detecting the GHB, Gamma hydroxybutyrate, also known as 'The Date Rape Drug,' is a very simple device, and also a very user-friendly one. (The most user friendly device developed by IDenta Corp, so far).

The test contains only a double step procedure:

--  Dipping the stick in the suspected liquid (no measuring necessary).
--  Replace the stick (with the suspected liquid) in the kit and breaking
    only one ampoule.
--  Watch the instant color change!!!
    

The new kit (as the company has already published in the past) will be inexpensive.

The end user price per kit will be between 5-7$ (less than the price published in August).

The official IDenta GHB Drug Detector product introduction will be at the California Narcotics Officers Association meeting to be held in November, in Reno, Nevada. At that time executives of IDenta (Mr. Yaacov Shoham -- CEO and Mr. Baruch Glattstein -- the chief scientist) and JANT Pharmacal, the company's U.S. marketing partner, will hold a formal news conference and provide further details of their plans for the entire line of IDenta-Accutest drug detectors.

The IDenta GHB Drug Detector will add a valuable new dimension to IDenta's line of drug detection products for law enforcement and civilian marketplaces, and again confirms that IDenta is the worldwide leader in the development of drug and explosive detectors which yield no false positives.

IDenta's preliminary research indicates that the GHB Detector has numerous applications both for law enforcement agencies who want to arrest the perpetrators of these dangerous substances, but as importantly it is going to be marketed as a preventative safe guard for young women who are the targets of these very regrettable crimes.

IDenta and its marketing team has already identified numerous potential consumer sale points for the new product such as night clubs, vending machines, drug stores, through on-line merchandisers and on college campuses. Law enforcement agencies around the world are expected to readily embrace the detector as a valuable tool for sting operations in night club districts where the GHB drug is known to be present, and has been used in the commission of serious crimes such as assault and rape against unsuspecting victims.

The marketing effort of the past three years has resulted in many alliances and agreements and as they come to fruition, the patient investors will be advised of many developments through press releases over the next several months.

The IDenta management team will attend very important meetings in the US and Canada in November and expect to see excellent marketing results from these meetings.

ABOUT GHB

Gamma hydroxybutyrate (GHB) is an illicit chemical that has become a major cause of drug-related comas in the US and other countries. In fact, the number of GHB overdoses in the United States has now out-paced overdoses from MDMA (Ecstasy). GHB was rejected by the American medical community as a sleep aid in the 1960s, but has become popular among many people for its ability to depress consciousness, resulting in euphoria and intoxication. It is also touted on the Internet as a sleep aid, an anti-depressant and weight loss product, although these uses are not substantiated by reality and may carry a potentially deadly twist.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a worldwide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com

    For Investor Relations in the US contact:
    Randy Jacobs
    Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For information about the Accutest - IDenta products in the US please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    www.accutest.net